Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sentra AM + Sentra PM
- Development stage
- Unknown
- Lead developer
- Targeted Medical Pharma
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Sentra AM and Sentra PM are medical foods developed by Physician Therapeutics (a subsidiary of Targeted Medical Pharma) designed for the dietary management of metabolic processes associated with specific clinical conditions. Sentra PM is a proprietary formulation of amino acids and polyphenols (including cocoa, ginkgo biloba, hawthorne berry, cinnamon, and flavonoids) designed to manage sleep disorders associated with depression, stress, and chronic pain by providing neurotransmitter precursors for serotonin and acetylcholine production. Sentra AM is intended for the dietary management of fatigue and cognitive disorders. These products are classified as medical foods rather than pharmaceutical drugs, containing Generally Recognized as Safe (GRAS) ingredients, and are intended for use under physician supervision to address specific amino acid deficiencies through nutritional pathways.
- Other names
- Sentra AM + Sentra PM
02
Targets
GluR (Glutamate receptors)AChR (Acetylcholine receptor)5-HT (Serotonin receptors)
Beyond the preview
Go deeper on Sentra AM + Sentra PM.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sentra AM + Sentra PM.